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Background:Obesity is a risk factor for chronic venous insufficiency and venous thromboembolism. The aim of this study
was to compare venous flow parameters of the lower limbs assessed by duplex ultrasound scanning in obese and nonobese
individuals according to body mass index (BMI).
Methods: Venous hemodynamics were studied in a prospective cohort study in nonobese (BMI <25 kg/m2) and obese
individuals (BMI >30 kg/m2). Diameter, flow volume, peak, mean, and minimum velocities were assessed.
Results: The study examined 36 limbs in 23 nonobese individuals and 44 limbs in 22 obese individuals. The diameter of
the femoral vein was significantly greater in obese (8.5 2.2 mm) vs nonobese (7.1 1.6 mm; P .0009) limbs. Venous
peak and minimum velocities differed between nonobese and obese individuals (14.8  7.2 vs 10.8  4.8 cm/s [P 
.0071] and 4.0  3.6 vs 1.7  6.3 cm/s [P  .056]). Calculation of venous amplitude and shear stress showed
significantly higher values in nonobese vs obese (18.8  9.4 vs 12.5  9.3 cm/s [P  .003] and 2.13  2.2 dyn/cm2 vs
1.6 2.7 dyn/cm2 [P .03]). Spearman rank correlation revealed a significant inverse correlation between waist-to-hip
ratios and waist circumference and venous peak velocity, mean velocity, velocities amplitude (peak velocity-minimum
velocity), and shear stress.
Conclusion: Lower limb venous flow parameters differ significantly between healthy obese and nonobese individuals.
These findings support the mechanical role of abdominal adipose tissue potentially leading to elevated risk for both
venous thromboembolism and chronic venous insufficiency. (J Vasc Surg 2010;52:664-8.)Several epidemiologic studies have given strong evi-
dence to the hypothesis that obesity is a risk factor for
chronic venous insufficiency (CVI) and venous thrombo-
embolism (VTE).1-3 Obesity can significantly affect the
development of metabolic syndrome with a cluster of car-
diovascular risk factors. Excess body weight is also related
to alterations in the coagulation system, including impaired
fibrinolytic activity and elevated plasma concentrations of
clotting factors.4 These alterations in endothelial function
and coagulation are thought to be relevant not only for
arterial but also for venous thrombosis.5 In addition to
these mechanisms, obesity is thought to predispose individ-
uals to venous stasis, which is a trigger of both deep vein
thrombosis and CVI.
Central obesity is thought to be associated with in-
creased intra-abdominal pressure (IAP) caused by abdom-
inal fat.6-8 Arvfidsson et al7 showed that the pressure in the
iliofemoral vein in morbidly obese patients was significantly
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664higher than in nonobese individuals.7 Likewise, surgical
weight reduction decreases urinary bladder pressure, a sur-
rogate marker of intra-abdominal pressure.8 The elevated
IAP is postulated to be transmitted to the extremities by the
femoral veins, leading to venous stasis and distensions of
the veins of the lower limbs favoring thrombosis and ve-
nous valve dysfunction.
To our knowledge, however, no human in vivo stud-
ies have confirmed this pathophysiologic assumption.
Color-coded duplex ultrasound (CCDU) imaging allows
for a noninvasive and accurate flow assessment of the
veins of the lower limbs.9 We hypothesized that venous
flow characteristics of the lower limb differ between
obese and nonobese individuals, inasmuch as obese peo-
ple exhibit lower flow velocities and a larger vein diam-
eter and that abdominal obesity correlates with venous
hemodynamic changes.
METHOD
The local Ethics Committee of the University Hospital
of Zurich approved this study (No. 1709). All participants
gave written informed consent.
Participants and study protocol. Venous hemody-
namics of the lower limbs were studied in 46 limbs of
nonobese individuals and in 44 limbs of obese individuals
in a prospective cohort design from April 2007 to March
2008 at a tertiary center for vascular disease. Inclusion
criteria were a body mass index (BMI)25 kg/m2 or30
kg/m2. Excluded were individuals with clinical signs of
CVI, DU evidence of venous valve dysfunction or outflow
obstruction, prior limb surgery or sclerotherapy, history
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ders, leg trauma or swelling, clinical signs of lymphedema,
history of chronic obstructive pulmonary disease, and car-
diac failure. The protocol entailed that participants provide
a medical history and undergo a clinical examination and
DU imaging to exclude venous incompetence or thrombo-
sis. Medical staff and students volunteered as study partic-
ipants.
BMI and waist-to-hip ratio. BMI was calculated as
the patient’s weight (kg)/height (m2). Waist circumfer-
ence was measured at a point midway between the costal
margin and iliac crest and in line with the mid-axilla. To
measure hip circumference, the greater trochanter was lo-
cated as the widest part of the hips at the level of the
buttock line. Waist and hip circumference were assessed
with the patient standing. The waist-to-hip ratio (WHR)
was calculated at the waist circumstance divided by hip
circumstance.
CCDU imaging. DU assessments were performed in
a tertiary referral hospital vascular laboratory by experi-
enced vascular physicians (T. W. and A. S.). Participants
were placed in a standardized supine position for all DU
scan measurements, with an upper body elevation of 10°.
CCDU was performed using the Accuson Sequioa 512
(Siemens AG, Medical Solutions, Zurich, Switzerland),
fitted with an 8-MHz linear scan head. The technical
settings (gain, contrast, and rejection) were optimized after
an initial evaluation and were maintained. Real-time gated
Doppler superimposed on B-mode imaging was used in the
evaluation of flow. Signals representing artefacts due to
erratic movement or forced breathing were discarded and
measurements repeated.
Doppler flow velocity tracings representing periods of 7
seconds were stored in memory and processed using auto-
mated wave form-enveloping DU software. Flow was stud-
ied at the femoral vein, 2 cm caudad to the confluence with
the deep femoral vein. Peak (PeakV), mean (MeanV), and
minimum (MinV) velocities were obtained.
Vein diameter was measured by placing the B-mode
callipers over the proximal and distal intimal-luminal inter-
faces. The cross-sectional area calculated as   diame-
ter2/4. This calculation enabled estimation of venous vol-
ume flow [Qvenous  MeanV  cross-sectional area].
Pulsatility index of venous flow [PIvenous] was calculated
[PIvenous  (PeakV  MinV)/MeanV], in keeping with
its estimation in arterial flow.10 The velocity amplitude
(Vamp) was calculated as the difference between PeakV –
MinV. At least four measurements were performed for each
of the evaluated parameters and then averaged. Venous wall
shear stress was calculated as 8    Vmean/diameter,
where blood viscosity () was assumed to be constant
(0.035 dyn/s/cm2).11
The applied method’s reproducibility for estimating
flow in smaller veins, such as perforators, has been re-
ported.12 Validation and reproducibility of this auto-
matic method have been described previously.9
Statistical analysis. Data are expressed as mean and
standard deviations. Data were analyzed with the Mann-Whitney U test for intergroup comparison between obese
and nonobese participants. Correlations between WHR/
waist circumference and venous flow parameters were cal-
culated by Spearman rank test. We did not test BMI and
flow parameters because BMI was used to differentiate
between obese and nonobese volunteers and was not a
continuous variable because overweight volunteers (BMI
25 to 29) were not included. Data analysis was performed
using SPSS software (SPSS Inc, Chicago, IL). A value of
P  .05 was considered to be significant.
RESULTS
All of the 46 control limbs and 44 limbs of obese
participants that were assessed were included in the analy-
ses. Baseline characteristics are reported in Table I.
Obesity and venous diameter and hemodynamics.
PeakV was significantly higher in controls (14.8  7.2
cm/s) than in obese participants (10.8  4.8 cm/s, P 
.0070; Fig 1). MinV tended to be lower in nonobese
participants (–4.0 3.6 cm/s) vs obese (–1.7 6.3 cm/s,
P .056; Fig 1). Obesity did not affect MeanV (4.8 5.1
in controls vs 3.8  3.5 in obese, P  .239; Fig 1). The
Table I. Baseline characteristics of control and obese
participants
Variable
Controls Obese
Pa(n  23) (n  22)
Female, No. 10 10 .99
Mean (SD) Mean (SD)
Age 49.7 (15.6) 53.5 (15.5) .013
Weight, kg 69 (10) 106 (18) .0001
Height, m 1.75 (0.08) 1.71 (0.1) .2700
Body mass index, kg/m2 22.4 (2.1) 36.2 (5.9) .0001
Waist circumference, cm 88 (10) 122 (11) .0001
Hip circumference, cm 93 (5) 114 (11) .0001
Waist-to-hip ratio 0.94 (0.07) 1.08 (0.07) .0001
SD, Standard deviation.
aMann-Whitney U test.
Fig 1. Mean values of peak (PeakV), minimal venous (MinV) and
mean venous (MeanV) blood flow velocities in the femoral vein of
nonobese andobeseparticipants.Errorbars show the standarddeviation.femoral vein diameter was significantly smaller in the con-
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mm, P  .0009). No significant difference of the flow
volume was found between the groups (controls, 89.5 
81.5 mL/min; obese, 99.4  54.7 mL/min, P  .12).
There were no significant differences between the left and
right leg for all assessed and calculated flow parameters
(PeakV, MinV, MeanV, diameter, Qvenous, PIvenous,
PeakV – MinV) for each group (data not shown).
Obesity and outflow resistance and shear stress.
Pulsatility index, indicating outflow resistance, was signifi-
cantly higher in obese participants (7.24  2.3) than in
controls (5.99  0.86; P  .02; Fig 2). Velocities ampli-
tude (PeakV – MinV) was significantly higher in controls
(18.8  9.4 cm/s) than in obese participants (12.5  9.3
cm/s, P .003; Fig 3). Lower mean velocities and greater
diameter results in a lower wall shear stress in obese people,
which was 1.2  0.0 dyn/cm2 vs 2.13  2.2 dyn/cm2 in
Fig 2. Mean of calculated venous pulsatility index in the femoral
vein of nonobese and obese participants. Error bars show the
standard deviation.
Fig 3. Mean of calculated venous velocity amplitudes in the fem-
oral vein of nonobese and obese participants. Error bars show the
standard deviation.controls (P  .03; Fig 4).Correlation between abdominal obesity and hemo-
dynamic parameters. Spearman rank correlation revealed
a significant inverse correlation between WHR or waist
circumference and PeakV, MeanV, velocities amplitude
(PeakV – MinV), and shear stress. Furthermore, a signifi-
cant positive correlation was found between WHR/waist
circumference for MinV and diameter (Table II). No sig-
nificant correlations were found for WHR and pulsatility
index and volume flow. However, the similar inverse and
positive correlations and lack of correlation, respectively,
were found when waist circumference only was taken as the
independent factor.
DISCUSSION
The results of the present study suggest that obesity
Fig 4. Mean of calculated venous shear stress in the femoral vein
of nonobese and obese participants. Error bars show the standard
deviation.
Table II. Waist-to-hip ratio and waist circumference in
correlation to lower limb venous flow characteristics in 22
obese and 23 nonobese individuals
Parameters Ra Pa
Waist-to-hip ratio
Peak velocity 0.44 .0001
Minimum velocity 0.429 .0001
Mean velocity 0.294 .0084
Peakminimum velocity 0.533 .0001
Pulsatility amplitude 0.197 .0768
Diameter 0.458 .0001
Volume flow 0.093 .4057
Shear stress 0.413 .0002
Waist
Peak velocity 0.378 .0007
Minimum velocity 0.314 .0050
Mean velocity 0.25 .0247
Peakminimum velocity 0.428 .0001
Pulsatility amplitude 0.153 .168
Diameter 0.456 .0001
Volume flow 0.143 .2031
Shear stress 0.369 .0009
aSpearman rank correlation.affects lower limb venous hemodynamic properties. The
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compared with nonobese participants. This could be inter-
preted as a result of elevated IAP transmitted to the femoral
veins and leading to vein wall distension. Increased stasis
and reduced forward flow velocity might be a consequence.
Indeed, we also found significant different hemodynamic
properties between the obese and nonobese participants.
PeakV was lower and MinV higher in the obese group.
Outflow obstruction caused by elevated IAP that results
from abdominal fat could explain these findings.
Likewise, pulsatility index, which is derived from peak,
minimum, and mean venous flow velocities, indicated a
higher outflow resistance in obese participants in our study.
The lower amplitude between peak and minimum venous
velocities in obese participants indicates a continuous flow.
This is in agreement with the greater vein diameter in the
obese group and previous reports on intravenous pressures
in obese people that is greater compared with nonobese
people.6-8
Abdominal obesity increases the IAP that is transmitted
to the veins of the lower limbs. This leads to greater tension
on the venous vessel wall, and hence, greater diameter.
Minimum venous velocity is usually slightly negative be-
cause venous valves close due to backflow. Although one
might expect higher venous backflow in obese participants,
our data indicate the opposite. It seems more likely that
through the greater pressure, the venous vessel wall is
permanently under greater tension in obese people; hence,
venous elasticity is attenuated. This potentially results in
venous valve dysfunction over time and might explain the
higher incidence of CVI in obese people.13 The signifi-
cantly lower venous shear stress in obese individuals sup-
ports that IAP in obesity results in venous stasis of the lower
limb given by the correlation between WHR or waist
circumference with velocity parameters and diameter.
We used the BMI for obese vs nonobese group defini-
tion because this marker of overweight and obesity is
established and correlates well with total body fat content
in adults.14 BMI, however, fails to consider the distribution
of fat.15 In view of the relationship between centrally
located fat and coronary heart disease, waist circumference
andWHR are accepted. We therefore used WHR and waist
circumference because this considers the abdominal fat
distribution.
Our data show a significantly lower value of shear stress
at the femoral vein in obese vs nonobese participants.
Lower shear stress might promote the release of factors that
reduce inflammation and the formation of reactive free
radicals.16 As described by Bergan et al16 decreased shear
stress might support development of CVI.
In addition, these alterations of inflammation and co-
agulation at the venous endothelium are further enhanced
by systemic changes in these parameters, which in addition
to CVI favor a VTE event. Although there are only a few
reports on human in vivo assessment of venous flow prop-
erties, abundant studies have shown that obesity is among
other intrinsic factors, such as previous VTE, CVI, chronic
heart failure, immobility, and cancer that increase the like-lihood for an adverse event.17 Numerous studies have
shown a clear relationship between obesity and the risk of
idiopathic VTE and pulmonary embolism, independent of
other recognized risk factors, with odds ratios of 2.42 in
two separate studies comparing BMI 30 with BMI
25.5,14,18,19 Even more striking is that a waist circumfer-
ence 100 cm confers up to a fourfold increased risk of
venous thromboembolism.18,20 Likewise, postthrombotic
syndrome is more likely to develop in obese individuals
after VTE.1 Excess body weight is a risk factor not only for
a first VTE event but also for recurrent VTE events, as
recently reported.21
Many researches in this field have focused on changes in
coagulation and reported that levels of D-dimer, fibrino-
gen, factor VIII, and factor IX significantly increased ac-
cording to categories of BMI. Interestingly, stasis as a third
factor in the Virchow triad has not been as extensively
assessed in a human in vivo study. Invasive human in vivo
studies have investigated the effect of abdominal obesity on
IAP and intravenous iliac pressure.7,8 These studies require
venous access or a bladder catheter. CCDU imaging, in
contrast, is noninvasive and allows for an assessment of flow
patterns. Fronek et al22 used CCDU imaging to investigate
the effect of aging on lower limb venous hemodynamics.22
Delis et al9,12 used CCDU scans in the assessment of
venous hemodynamics of perforators and to determine the
effect of posture on deep vein flow patterns.
Although we studied a rather small group of obese and
nonobese individuals, the findings are striking considering
the limited numbers of legs investigated and underline that
abdominal obesity is associated with lower limb outflow
impairment.
Our study sample is too limited to stratify venous flow
impairment for categories of BMI. Furthermore, it does
not allow conclusions about venous velocities in patients
with moderate overweight (BMI, 25-30 kg/m2). Our data
only indicate that an impairment of lower limb venous
outflow is observed in obese individuals, but not whether
this translates into an increased risk for VTE or CVI. This
link has recently been reported by larger, event-driven
cohort studies.17,18,20,21 However, other factors such am-
bulatory activity, ankle-joint function, and gait pattern
might be involved as well.
The nonblinded manner of data assessment by DU
must be considered a shortcoming in our study protocol.
Blinding the observer in our study setting was impossible,
and measurements were strictly standardized to overcome
this. This standardization and the applied exclusion criteria
were also needed tominimize the effect of other factors that
might affect venous flow, such as movements, posture, or
respiration pattern.
We found no differences between the right and the left
leg regarding the assessed DU hemodynamic direct and
indirect parameters (data not shown). Iliac vein compres-
sion is much more prevalent in women than in men.23 Of
course, it would have been interesting to provide more
precise information about the venous system of the partic-
ipants in our trial, such as by means of venous pressure
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puted tomography scanning. Nevertheless, our data indi-
cate that a simple, noninvasive assessment by DU imaging
is sufficient to detect differences in flow patterns with
respect to obesity, although there was no matching for age
between obese and nonobese individuals. We cannot ex-
clude this as a possible confounder even if this does not
seem very likely.
CONCLUSIONS
Our findings support the hypothesis that obesity has a
relevant influence on lower limb venous hemodynamic
parameters. Whether this may explain the increased risk for
CVI and VTE in obese participants remains speculative and
should be further investigated.
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